Open Access
Editorial
Issue
Med Buccale Chir Buccale
Volume 23, Number 3, October 2017
Page(s) 121 - 122
Section Éditorial / Editorial
DOI https://doi.org/10.1051/mbcb/2017014
Published online 08 November 2017

Oral Medicine (OM) is generally defined as the branch of dentistry related to the oral health care of patients suffering from chronic recurrent and medically related disorders of the mouth and maxillofacial region with their diagnosis and mostly non-surgical management. OM was originally called dental medicine and it is sometimes termed oral and maxillofacial medicine and, mainly in the Ibero-American world and in Southern Europe, also stomatology [1].

Scopes and definition of OM are not the same everywhere and these differences are likely the result of cultural, economic, differences, heterogeneity of settings and health care systems. However, there is a broad agreement about clinical activities as OM practice in mainly devoted to the diagnosis and management of oral mucosal lesions, salivary gland disorders, and oral manifestations of dermatologic, gastrointestinal, infectious diseases (such as but not restricted to HIV and HCV), and facial pain [2].

OM works closely with other Dental (mainly Oral Pathology, Oral Radiology, Periodontology, Geriatric Dentistry, Oral Surgery, Special Need Dentistry) and Medical (especially Oral and Maxillo-Facial Surgery, Dermatology, Otorhinolaryngology, Gastroenterology, Ophthalmology, Rheumatology, Neurology) specialties.

OM has an active research component: just as an example and without any wish to be comprehensive, land marking discoveries published by OM colleagues include fields as Infectious diseases [3,4], Hepatology [5], Oncology [6], Rheumatology [7], and Pharmacology [8].

OM is recognized as a specialty by Local Registering Authorities in Europe in Croatia, Israel and United Kingdom whereas OM training is a distinct field of study in Finland, Greece, Ireland, Italy, Spain, Sweden [2].

The European Association of Oral Medicine (EAOM) was founded 1998 in London by Professors Crispian Scully (United Kingdom) and Isaac van der Waal (Netherlands) along with Professors Sir David Mason, Tony Axéll (Scandinavia), Antonio Azul (Portugal), and Stephen Challacombe (United Kingdom) [1] and I am honoured to be the 10th President of the Society.

EAOM aims to improve clinical care in the field of OM and to promote education and research in OM and also to inform governments and other official institutions of the significance of OM for oral and systemic health. The latter is particularly relevant for a broader official recognition of OM in Europe and worldwide.

EAOM activities are not just limited to Europe and the Society has a truly international vocation and is willing to engage with any dentist and/or medical doctor who share an interest in OM regardless of the geographic and training background.

EAOM has, for example, a consistent number of fellows from USA, Japan, Brazil and Thailand.

We run increasingly successful biannual meetings. The next one will be held in September 2018 in Gothenburg, Sweden, jointly with the World Workshop of Oral Medicine and we will celebrate the 20th Anniversary of EAOM.

EAOM is also strongly committed to support young colleagues who are starting their career in OM through monetary competitive prizes and travel bursaries.

Kindly keep in touch through EAOM web-site (http://www.eaom.eu/) and/or feel free to contact myself or the EAOM secretary if you are thinking to join our big OM community or simply to gain more information about our activities and to discover the advantage to be an EAOM member.

References

  1. Scully C, Miller CS, Aguirre Urizar JM, Alajbeg I, Almeida OP, Bagan JV et al. Oral medicine (stomatology) across the globe: birth, growth, and future. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;121:149-157. [CrossRef] (In the text)
  2. Bez C, Sklavounou A, Carrozzo M. Oral medicine in Europe: past, present and future. Br Dent J 2017 DOI: 10.1038/sj.bdj.2017.891. (In the text)
  3. De Souza YG, Greenspan D, Felton JR, Hartzog GA, Hammer M, Greenspan JS. Localization of Epstein-Barr virus DNA in the epithelial cells of oral hairy leukoplakia by in situ hybridization of tissue sections. N Engl J Med 1989;320:1559-1560. [CrossRef] [PubMed] (In the text)
  4. Maitland NJ, Cox MF, Lynas C, Prime SS, Meanwell CA, Scully C. Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 1987;56:245-250. [CrossRef] [PubMed] (In the text)
  5. Carrozzo M, Quadri R, Latorre P, Pentenero S, Berytolusso G, Gandolfo S, Negro F. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol 2002;37:364-369. [CrossRef] (In the text)
  6. King GN, Healy CM, Glover MT, Kwan JT, Williams DM, Leigh IM, Worthington HV, Thornhill MH et al. Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. N Engl J Med 1995;332:1052-1057. [CrossRef] [PubMed] (In the text)
  7. Shiboski CH, Shiboski SC, Seror R et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35-45. [CrossRef] [PubMed] (In the text)
  8. Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet 2015;385:1219-1228. [CrossRef] [PubMed] (In the text)

© The author, 2017

Licence Creative Commons
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.